根据条款,AnnJi将获得300万美元的预付款,并有权获得未来的开发、监管和商业化里程碑付款,以...查看全文
港美情报站2022-09-23 18:02
与葛兰素史克签大单!$Spero治疗(SPRO)$ 荣登妖股涨幅榜榜首
医药股历来是妖股集中营,昨日#美股# 涨幅前二的#妖股# 都是生物医药行业。昨日妖股涨幅榜榜首是SPRO,盘中最大涨幅接近300%,收盘涨幅也有167%。
消息面上,昨日,葛兰素史克和Spero Therapeutics已就tebipenem pivoxil hydrob...查看全文
格隆汇4月18日丨Avenue Therapeutics盘前涨15.65%,报1.33美元。Avenue Therapeutics周一表示,3月9日与美国FDA就开发用于治疗术后疼痛的静脉注射曲马多(IV Tramadol)举行的官方纪要表明,该机构在拟议研究方案... 网页链接
$Avenue Therapeutics(ATXI)$ 内部交易: 2019-01-30,Director,Herskowitz Neil ,买入,650普通股, $5.91
$Avenue Therapeutics(ATXI)$ 内部交易: 2019-01-29,Director,Herskowitz Neil ,买入,8553普通股, $5.91
$Avenue Therapeutics(ATXI)$ 内部交易: 2019-01-28,Director,Herskowitz Neil ,买入,1447普通股, $5.84
$Avenue Therapeutics(ATXI)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-01-25 AccNo: 0001144204-19-002849 Size: 191 KB 网页链接
$Avenue Therapeutics(ATXI)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-01-22 AccNo: 0001493152-19-000824 Size: 169 KB 网页链接
$Avenue Therapeutics(ATXI)$ DEFM14A - Definitive proxy statement relating to merger or acquisition Filed: 2018-12-21 AccNo: 0001144204-18-065906 Size: 3 MB 网页链接
$Avenue Therapeutics, Inc.(ATXI)$ PREM14A - Preliminary proxy statements relating to merger or acquisition Filed: 2018-12-11 AccNo: 0001571049-18-000574 Size: 2 MB 网页链接
$Avenue Therapeutics, Inc.(ATXI)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2018-11-23 AccNo: 0001140361-18-043612 Size: 506 KB 网页链接
$Avenue Therapeutics, Inc.(ATXI)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-14 AccNo: 0001144204-18-060006 Size: 2 MB 网页链接
$Avenue Therapeutics, Inc.(ATXI)$ 8-K - Current report Filed: 2018-11-14 AccNo: 0001144204-18-059979 Size: 113 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接